Benicar (Olmesartan) Associated With Sprue-Like Enteropathy, Which Is A Chronic / Severe Diarrhea Condition That Can Be Misdiagnosed As Celiac Disease

This Diarrhea With Weight Loss Is Also A Side Effect Of Benicar HCT, Azor, And Tribenzor — Other Blood Pressure Medicines Containing Olmesartan

(Posted by at DrugInjuryWatch.com)

An association between the serious side effect sprue-like enteropathy and the oral angiotensin-receptor blockers (ARBs) Benicar, Benicar HCT, Azor, and Tribenzor and has been getting increased attention in the medical literature.

As pointed out by the FDA in July 2013 when it issued this MedWatch alert, "FDA Drug Safety Communication: FDA approves label changes to include intestinal problems (sprue-like enteropathy) linked to blood pressure medicine olmesartan medoxomil", severe and chronic diarrhea with substantial weight loss has been reported in patients taking Benicar and the other related drugs months to years after they first started using these blood pressure pills.

_____________________________________________________________________

 

Free Benicar Case Evaluation 

Strictly Confidential, No Obligation.

______________________________________________________________________________

The most recent medical article we have seen on this still emerging drug safety issue was published online by the Journal of Pharmacy Practice in late March 2014.  From the Abstract for "A Review of Current Evidence of Olmesartan Medoxomil Mimicking Symptoms of Celiac Disease" we get this information:

Objective: To review the evidence of an association between [Benicar, Benicar HCT, Azor, and Tribenzor (olmesartan medoxomil)] and symptoms mimicking celiac disease….

Data Sources: Literature was searched in PubMed (1965-November 2013) using the key words or MeSH terms olmesartan, enteropathy, celiac disease, sprue, and diarrhea.

Data Synthesis: There have been recent implications of [Benicar, Benicar HCT, Azor, and Tribenzor (olmesartan medoxomil)] being linked to symptoms mimicking celiac disease. Investigators first identified the association in 22 patients who presented with presumed refractory celiac disease. Upon further evaluation, it was discovered that these symptoms improved when [Benicar, Benicar HCT, Azor, or Tribenzor (olmesartan medoxomil)] was discontinued. In response to this report, additional case studies have been published.

Conclusions: There is growing evidence supporting the association between [Benicar, Benicar HCT, Azor, and Tribenzor (olmesartan medoxomil)] and sprue-like symptoms; however, further research is warranted. These symptoms can be life threatening and clinicians should be aware of the potential association.

For more information you can take a look at our previous articles:

Of course, we are continuing to monitor this drug safety issue concerning Benicar, Benicar HCT, Azor, and Tribenzor.

______________________________________________________________________________

DrugInjuryLaw.com: Current Legal And Medical Information About Prescription Drug Side Effects  (All website content by attorney Tom Lamb)

Drug Injury Case Evaluation – Free & Confidential  (Legal case review done by attorney Tom Lamb)

Leave a Reply

Your email address will not be published. Required fields are marked *